The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
miR‐155 modulates microglia‐mediated immune response by down‐regulating SOCS‐1 and promoting cytokine and nitric oxide production
Open accessAbstract
Innate immunity constitutes the first line of defence against both external and endogenous threats in the brain, and microglia cells are considered key mediators of this process. Recent studies have shown that microRNAs (miRNAs) may play a determinant role in the regulation of gene expression during innate immune responses. The major goal of this work was to investigate the contribution of a specific miRNA - miR-155 - to the modulation of the microglia-mediated immune response. For this purpose, in vitro studies were performed in N9 microglia cells to evaluate changes in the levels of this miRNA following microglia activation. A strong up-regulation of miR-155 expression was observed following microglia exposure to lipopolysaccharide, which was consistent with a decrease in the levels of the suppressor of cytokine signalling 1 (SOCS-1) protein, a key inhibitor of the inflammatory process and a predicted target of miR-155. The miR-155 knockdown by anti-miRNA oligonucleotides up-regulated SOCS-1 mRNA and protein levels and significantly decreased the production of nitric oxide and the expression of inflammatory cytokines and inducible nitric oxide synthase. Finally, treatment of neuronal primary cultures with conditioned medium obtained from microglia cells, in which miR-155 was inhibited before cell activation, decreased inflammatory-mediated neuronal cell death. Overall, our results show that miR-155 has a pro-inflammatory role in microglia and is necessary for the progression of the immune response through the modulation of SOCS-1, suggesting that, in a chronic inflammatory context, miR-155 inhibition can have a neuroprotective effect.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cardoso et al., based on findings in other myeloid-derived cells, demonstrated that miR-155 is induced by LPS in a mouse N9 microglia cell line and in primary cultures. Similar to other authors [244], they confirmed targeting of the suppressor of the cytokine signaling 1 gene (SOCS1) by miR-155.”
From MicroRNAs as Regulators of Phagocytosis (2022) · cites this paper as [237]
In the citing paper
“For example, neuron-derived EVs enriched in miR-132-3p or miR-124-3p can reprogram glial states, while glial EV cargo such as miR-155, miR-21-5p, and miR-146a feeds back onto neurons and other glia to propagate inflammatory or compensatory signals (Aloi et al., 2023; Cardoso et al., 2011; Fan et al., 2020; Gaudet et al., 2017; Guedes et al., 2014; Han et al., 2020; Lukiw et al., 2008; Saba et al.,”
From Cell-specific MicroRNA networks orchestrate the pathogenesis of Alzheimer’s disease (2026) · cites this paper as Cardoso et al., 2011
In the citing paper
“MiR-155 is one of the strongest determinants of microglial pathogenicity. Its upregulation in AD microglia enhances NF-κB signaling, increases production of pro-inflammatory cytokines, and reduces phagocytic Aβ clearance, thereby worsening plaque burden and neuronal injury (Cardoso et al., 2011; Guedes et al., 2014).”
From Cell-specific MicroRNA networks orchestrate the pathogenesis of Alzheimer’s disease (2026) · cites this paper as Cardoso et al., 2011
In the citing paper
“MiR-155 is also induced in reactive astrocytes and is associated with pro-inflammatory glial reprogramming.”
From Cell-specific MicroRNA networks orchestrate the pathogenesis of Alzheimer’s disease (2026) · cites this paper as Cardoso et al., 2011
In the citing paper
“Astrocytic and microglial miRNAs, including miR-21-5p, miR-155, miR-33, miR-146a, and miR-181c-5p, govern processes such as NF-κB–dependent inflammatory activation, ApoE/ABCA1 lipid pathways, and microglial plaque-associated phenotypes (Aloi et al., 2023; Cardoso et al., 2011; Fan et al., 2020; Garcia et al., 2022; Hansen et al., 2017; Hutchison et al., 2013; Li et al., 2024; Lukiw et al., 2008; O”
From Cell-specific MicroRNA networks orchestrate the pathogenesis of Alzheimer’s disease (2026) · cites this paper as Cardoso et al., 2011
In the citing paper
“Thus, miR-155 and miR-146a were shown to increase in the microglial cells in response to stimulation with Lipopolysaccharides (LPS) and Polyinosinic-polycytidylic acid (poly(I:C), respectively, and they seem to play a fundamental role in the microglial inflammatory profile [13,14].”
From miR-155 induction in microglial cells suppresses Japanese encephalitis virus replication and negatively modulates innate immune responses (2014) · cites this paper as [13]
In the citing paper
“Recently, a study showed that miR-155 leads to the increase of inflammatory factors such as inducible nitrogen synthase (iNOS), IL-6 and TNF-α, and thus the neurotoxic response for activated microglia to switch to the M1 phenotype (Cardoso et al. 2012).”
From MiR-124 and MiR-155 as Therapeutic Targets in Microglia-Mediated Inflammation in Multiple Sclerosis (2025) · cites this paper as Cardoso et al. 2012
In the citing paper
“A study showed that non-viral vector can help silencing miR-155 in microglia before activation, decrease NO release and inflammatory factors, and include TNF-α and IL-6 in the microenvironment via upregulation of SOCS-1, a direct target of miR-155. This method can improve neuronal viability and inhibit microglial activation through miRNA modulation in microglial cells (Cardoso et al. 2012).”
From MiR-124 and MiR-155 as Therapeutic Targets in Microglia-Mediated Inflammation in Multiple Sclerosis (2025) · cites this paper as Cardoso et al. 2012
Citations
Cites
Taganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110
MicroRNA-155 is induced during the macrophage inflammatory response
O'Connell, R. M., Taganov, K. D., Boldin, M. P., Cheng, G., & Baltimore, D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610731104 · Cited by 1,866
Requirement of bic/microRNA-155 for Normal Immune Function
Rodriguez, A., Vigorito, E., Clare, S., Warren, M. V., Couttet, P., Soond, D. R., van Dongen, S., Grocock, R. J., Das, P. P., Miska, E. A., et al. (2007) · Science · doi:10.1126/science.1139253 · Cited by 1,833
Inflammation in neurodegenerative diseases
Amor, S., Puentes, F., Baker, D., & Van Der Valk, P. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03225.x · Cited by 1,355
Tili, E., Michaille, J.-J., Cimino, A., Costinean, S., Dumitru, C. D., Adair, B., Fabbri, M., Alder, H., Liu, C. G., Calin, G. A., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5082 · Cited by 1,304
Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis
Stańczyk, J., Pedrioli, D. M. L., Brentano, F., Sánchez‐Pernaute, O., Kolling, C., Gay, R. E., Detmar, M. J., Gay, S., & Kyburz, D. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23386 · Cited by 911
miR-155 gene: A typical multifunctional microRNA
Faraoni, I., Antonetti, F. R., Cardone, J., & Bonmassar, E. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.02.013 · Cited by 815
MicroRNAs: Novel Regulators Involved in the Pathogenesis of Psoriasis?
Sonkoly, E., Wei, T., Janson, P. C. J., Sääf, A., Lundeberg, L., Tengvall-Linder, M., Norstedt, G., Alenius, H., Homey, B., Scheynius, A., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000610 · Cited by 754
Jiang, S., Zhang, H.-W., Lu, M.-H., He, X.-H., Li, Y., Gu, H., Liu, M.-F., & Wang, E.-D. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4250 · Cited by 679
Flagged first, then by citations
Research works printed but not linked: 1
- 10.1097/01.WCB.0000061881.75234.5E · DOI · Paper page
Cited by
Sorted by citations
Items 101–200 of 337
Juknat, A., Gao, F., Coppola, G., Vogel, Z., & Kozela, E. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212039 · Cited by 67
O’Sullivan, M. P., Looney, A.-M., Moloney, G. M., Finder, M., Hallberg, B., Clarke, G. A., Boylan, G. B., & Murray, D. M. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.4182 · Cited by 63
Kumar, A., Henry, R. J., Stoica, B. A., Loane, D. J., Abulwerdi, G. A., Bhat, S. A., & Faden, A. I. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.253955 · Cited by 63
Lynch, M. A. (2013) · Immunology · doi:10.1111/imm.12156 · Cited by 64
Circulating Inflammatory miRNAs Associated with Parkinson’s Disease Pathophysiology
Oliveira, S. R., Dionísio, P. A., Guedes, L. C., Gonçalves, N., Coelho, M. M., Rosa, M. M., Amaral, J. D., Ferreira, J. J., & Rodrigues, C. M. P. (2020) · Biomolecules · doi:10.3390/biom10060945 · Cited by 59
Cianciulli, A., Calvello, R., Porro, C., Trotta, T., & Panaro, M. A. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.07.005 · Cited by 59
Bulygin, K. V., Beeraka, N. M., Saitgareeva, A. R., Nikolenko, V. N., Фанилевич, Г. И., Beylerli, O., Ахмадеева, Л. Р., Михалева, Л. М., Solis, L. F. T., Herrera, A. S., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186728 · Cited by 60
El-Sahar, A. E., Shiha, N. A., Sayed, N. S. E., & Ahmed, L. A. (2020) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa078 · Cited by 58
Li, C., Yin, W., Yu, N., Zhang, D., Zhao, H., Liu, J., Liu, J., Pan, Y., & Lin, L. (2019) · Oral Diseases · doi:10.1111/odi.13198 · Cited by 58
Perdaens, O., & Pesch, V. V. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2021.811518 · Cited by 62
Pandey, R., Bakay, M. A., & Hakonarson, H. H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1271102 · Cited by 59
Inflamma-MicroRNAs in Alzheimer’s Disease: From Disease Pathogenesis to Therapeutic Potentials
Liang, Y., & Wang, L. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.785433 · Cited by 56
Walker, D. G., Whetzel, A. M., & Lue, L. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.09.052 · Cited by 57
Regulatory function of microRNAs in microglia
Brites, D. M. T. O. (2020) · Glia · doi:10.1002/glia.23846 · Cited by 59
Vaz, A. R., Pinto, S., Ezequiel, C., Cunha, C., Carvalho, L. A., Moreira, R., & Brites, D. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00109 · Cited by 55
miR-155 Dysregulation and Therapeutic Intervention in Multiple Sclerosis
McCoy, C. E. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-10-5987-2_5 · Cited by 46
Chen, X., Wang, X., Cui, Z., Luo, Q., Jiang, Z., Huang, Y., Jiang, J., Qiu, J., Li, Y., Yu, K., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.79784 · Cited by 53
Lescher, J., Paap, F., Schultz, V., Redenbach, L., Scheidt, U., Rosewich, H., Nessler, S., Fuchs, E., Gärtner, J., Brück, W., et al. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.02.012 · Cited by 53
MicroRNA-155 deletion reduces anxiety- and depressive-like behaviors in mice
Fonken, L. K., Gaudet, A. D., Gaier, K. R., Nelson, R. J., & Popovich, P. G. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.10.019 · Cited by 56
Yin, H., Song, S., & Pan, X. (2017) · Journal of Inflammation · doi:10.1186/s12950-017-0162-7 · Cited by 53
Hazra, B., Chakraborty, S., Bhaskar, M., Mukherjee, S., Mahadevan, A., & Basu, A. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900003 · Cited by 51
MicroRNAs as Novel Regulators of Neuroinflammation
Ksiazek-Winiarek, D. J., Kacperska, M. J., & Glabinski, A. R. (2013) · Mediators of Inflammation · doi:10.1155/2013/172351 · Cited by 51
Zhang, Y., Shen, K., Bai, Y., Lv, X., Huang, R., Zhang, W., Chao, J., Nguyen, L. K., Hua, J., Gan, G., et al. (2016) · Autophagy · doi:10.1080/15548627.2016.1191723 · Cited by 51
Regulation of microglia by glutamate and its signal pathway in neurodegenerative diseases
Zhang, X., Wang, D., Zhang, B., Zhu, J., Zhou, Z., & Cui, L. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.04.001 · Cited by 53
Westwood, M., Ramaekers, B., Lang, S., Armstrong, N., Noake, C., de Kock, S., Joore, M., Severens, J., & Kleijnen, J. (2016) · Health Technology Assessment · doi:10.3310/hta20670 · Cited by 49
Li, C., Ren, J., Zhang, M., Wang, H., Fang, Y., Wu, J., & Tang, Y. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04536-3 · Cited by 52
Induction of miR-155 after Brain Injury Promotes Type 1 Interferon and has a Neuroprotective Effect
Harrison, E. B., Emanuel, K., Lamberty, B. G., Morsey, B. M., Li, M., Kelso, M. L., Yelamanchili, S. V., & Fox, H. S. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00228 · Cited by 48
MicroRNA-155 Promotes Heat Stress-Induced Inflammation via Targeting Liver X Receptor α in Microglia
Li, P., Wang, G., Zhang, X., He, G., Luo, X. G., Yang, J., Luo, Z., Shen, T., & Yang, X. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00012 · Cited by 47
New epigenetic players in stroke pathogenesis: From non-coding RNAs to exosomal non-coding RNAs
Mahjoubin‐Tehran, M., Rezaei, S., Jesmani, A., Birang, N., Morshedi, K., Khanbabaei, H., Khan, H. Z., Piranviseh, A., Nejati, M., Aschner, M., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111753 · Cited by 48
miR-30 overexpression promotes glioma stem cells by regulating Jak/STAT3 signaling pathway
Che, S., Sun, T., Wang, J., Jiao, Y., Wang, C., Meng, Q., Qi, W., & Yan, Z. (2015) · Tumor Biology · doi:10.1007/s13277-015-3400-8 · Cited by 46
Epigenetic regulation of inflammation in stroke
Ng, G. Y.-Q., Lim, Y.-A., Sobey, C. G., Dheen, S. T., Fann, D. Y., & Arumugam, T. V. (2018) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286418771815 · Cited by 48
Sadik, N. A., Rashed, L. A., & Abd‐Elmawla, M. A. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s295939 · Cited by 47
Jones, T. A., Jeyapalan, J. N., Forshew, T., Tatevossian, R., Lawson, A. R. J., Patel, S. N., Doctor, G. T., Mumin, M., Picker, S. R., Phipps, K. P., et al. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0266-3 · Cited by 44
Natekar, J. P., Rothan, H. A., Arora, K., Strate, P. G., & Kumar, M. (2019) · Viruses · doi:10.3390/v12010009 · Cited by 44
miR‐155 Knockdown Protects against Cerebral Ischemia and Reperfusion Injury by Targeting MafB
Zhang, L., Liu, C., Huang, C., Xu, X., & Teng, J. (2020) · BioMed Research International · doi:10.1155/2020/6458204 · Cited by 43
Burgaletto, C., Platania, C. B. M., Benedetto, G. D., Munafò, A., Giurdanella, G., Federico, C., Caltabiano, R., Saccone, S., Conti, F., Bernardini, R., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04165-x · Cited by 43
Kim, J.-H., Jou, I., & Joe, E.-H. (2014) · Experimental Neurobiology · doi:10.5607/en.2014.23.2.148 · Cited by 43
Sarkar, S. N., Russell, A. E., Engler-Chiurazzi, E. B., Porter, K. N., & Simpkins, J. W. (2018) · Aging and Disease · doi:10.14336/ad.2018.0409 · Cited by 43
Vargas, A. M., Rivera-Rodriguez, D. E., & Martinez, L. R. (2020) · Molecular Immunology · doi:10.1016/j.molimm.2020.03.013 · Cited by 40
Tarassishin, L., Bauman, A., Suh, H.-S., & Lee, S. C. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9360-5 · Cited by 40
Mazloom, H., Alizadeh, S., Pasalar, P., Nasli‐Esfahani, E., & Meshkani, R. (2015) · Cytokine · doi:10.1016/j.cyto.2015.07.007 · Cited by 40
Falcão, A. S., Carvalho, L. A. R., Lidónio, G. M. D. C., Vaz, A. R., Lucas, S. D., Moreira, R., & Brites, D. M. T. O. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00250 · Cited by 38
Astrocytic microRNAs and transcription factors in Alzheimer’s disease and therapeutic interventions
Nassar, A., Kodi, T., Satarker, S., Chowdari Gurram, P., Upadhya, D., SM, F., Mudgal, J., & Nampoothiri, M. (2022) · Cells · doi:10.3390/cells11244111 · Cited by 38
Ponnusamy, V., Kapellou, O., Yip, E., Evanson, J., Wong, L., Michael-Titus, A. T., Yip, P. K., & Shah, D. K. (2015) · Pediatric Research · doi:10.1038/pr.2015.276 · Cited by 38
Xue, F., Sun, D., Wang, Z., Yu, Z., Liu, W., Pu, Y., Wang, D., Huang, A., Liu, M., Xiang, Z., et al. (2017) · Neuroscience Bulletin · doi:10.1007/s12264-017-0153-y · Cited by 38
Yip, P. K., Bowes, A. L., Hall, J. C. E., Burguillos, M. A., Ip, T. H. R., Baskerville, T., Liu, Z.-H., Mohamed, M. A. E. K., Getachew, F., Lindsay, A. D., et al. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz073 · Cited by 38
Zhao, K., Liu, J., Sun, T., Zeng, L., Li, Z., Li, Z., & Liu, R. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.02.016 · Cited by 42
The p53 Transcriptional Network Influences Microglia Behavior and Neuroinflammation
Aloi, M. S., Su, W., & Garden, G. A. (2015) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v35.i5.40 · Cited by 35
miRNAs Participate in MS Pathological Processes and Its Therapeutic Response
Wu, T., & Chen, G. (2016) · Mediators of Inflammation · doi:10.1155/2016/4578230 · Cited by 37
MicroRNAs and their potential therapeutic applications in neural tissue engineering
Nguyen, L. H., Diao, H. J., & Chew, S. Y. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.05.007 · Cited by 35
Yang, B., Yang, R., Xu, B., Fu, J., Qu, X., Li, L., Dai, M., Tan, C., Chen, H., & Wang, X. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02165-4 · Cited by 35
CSF microRNAs discriminate MS activity and share similarity to other neuroinflammatory disorders
Perdaens, O., Dang, H. A., D’Auria, L., & Pesch, V. V. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000673 · Cited by 34
Nie, L., Cai, S.-Y., Sun, J., & Chen, J. (2018) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2018.11.030 · Cited by 35
MicroRNAs and MAPKs: Evidence of These Molecular Interactions in Alzheimer’s Disease
Raffaele, I., Silvestro, S., & Mazzon, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054736 · Cited by 33
Petralla, S., Chirico, F. D., Miti, A., Tartagni, O., Massenzio, F., Poeta, E., Virgili, M., Zuccheri, G., & Monti, B. (2021) · Biomolecules · doi:10.3390/biom11020306 · Cited by 37
miR‑155 mediates inflammatory injury of hippocampal neuronal cells via the activation of microglia
Sun, X., Song, M.-F., Song, H., Wang, Y., Luo, M., & Yin, L. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.9917 · Cited by 32
Zulfiqar, Z., Shah, F. A., Shafique, S., Alattar, A., Ali, T., Alvi, A. M., Rashid, S., & Li, S. (2020) · Journal of Inflammation Research · doi:10.2147/jir.s284471 · Cited by 32
RetractedBoswellic acids as promising agents for the management of brain diseases
Rajabian, A., Farzanehfar, M., Hosseini, H., Arab, F. L., & Nikkhah, A. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121196 · Cited by 33
Wan, S., Ashraf, U., Ye, J., Duan, X., Zohaib, A., Wang, W., Chen, Z., Zhu, B., Li, Y., Chen, H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12395 · Cited by 32
Majer, A., Caligiuri, K. A., Gale, K. K., Niu, Y., Phillipson, C. S., Booth, T. F., & Booth, S. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169081 · Cited by 31
Current progress of miRNA-derivative nucleotide drugs: modifications, delivery systems, applications
Asakiya, C., Zhu, L., Yuhan, J., Zhu, L., Huang, K., & Xu, W. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2063835 · Cited by 31
Kołosowska, N., Gotkiewicz, M., Dhungana, H., Giudice, L., Giugno, R., Box, D., Huuskonen, M. T., Korhonen, P., Scoyni, F., Kanninen, K. M., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01870-w · Cited by 30
miR-206 modulates lipopolysaccharide-mediated inflammatory cytokine production in human astrocytes
Duan, X., Zohaib, A., Yun-chun, L., Zhu, B., Ye, J., Wan, S., Xu, Q., Song, Y., Chen, H., & Cao, S. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.10.006 · Cited by 30
MicroRNAs and Tumor Vasculature Normalization: Impact on Anti-Tumor Immune Response
Matejuk, A., Collet, G., Nadim, M., Grillon, C., & Kiéda, C. (2013) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-013-0231-4 · Cited by 30
Obora, K., Onodera, Y., Takehara, T., Frampton, J. P., Hasei, J., Ozaki, T., Teramura, T., & Fukuda, K. (2017) · Scientific Reports · doi:10.1038/srep43604 · Cited by 30
Greco, R., Demartini, C., Zanaboni, A. M., Blandini, F., Amantea, D., & Tassorelli, C. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24101 · Cited by 29
Duan, Z., Zhang, J., Li, J., Pang, X., & Wang, H. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00416 · Cited by 30
Lei, K., Du, W., Lin, S., Yang, L., Xu, Y., Gao, Y., Xu, B., Tan, S., Xu, Y. F., Qian, X. H., et al. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.04.049 · Cited by 30
Wang, J., Li, D., Hou, J., & Lei, H. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.8221 · Cited by 30
Li, L., Qi, C., Liu, Y., Shen, Y., Zhao, X., Qin, H., Zhang, Y., & Yu, T. (2021) · Bioengineered · doi:10.1080/21655979.2021.1969195 · Cited by 29
“For example, as an inflammatory promotor, miR-155 worsens the inflammation of microglia while miR-146a acts as an inflammatory inhibitor that is capable of reducing inflammation [16,17].”
BackgroundThe diverse roles of macrophages in metabolic inflammation and its resolution
Ray, A. G., Odum, O., Wiseman, D., & Weinstock, A. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1147434 · Cited by 31
Ksiazek-Winiarek, D., Szpakowski, P., Turniak, M., Szemraj, J., & Glabinski, A. (2017) · Journal of Molecular Neuroscience · doi:10.1007/s12031-017-0981-2 · Cited by 26
Neurovascular inflammation in the pathogenesis of brain arteriovenous malformations
Krithika, S., & Surendran, S. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30226 · Cited by 29
MicroRNA Networks in Cognition and Dementia
Blount, G. S., Coursey, L., & Kocerha, J. (2022) · Cells · doi:10.3390/cells11121882 · Cited by 29
Liu, X., Wang, C., Huang, S.-F., Chen, Q., Hu, Y., Zhou, L. F., & Gu, Y. (2016) · Scientific Reports · doi:10.1038/srep24073 · Cited by 30
Zhao, R., Dong, R., Yang, Y., Wang, Y., Ma, J., Wang, J., Li, H., & Zheng, S. (2017) · Pediatric Research · doi:10.1038/pr.2017.87 · Cited by 29
Ellithy, G., El‐Bakly, W. M., Matboli, M., Abd-Alkhalek, H. A., Masoud, S. I., & Hamza, M. (2016) · Translational research · doi:10.1016/j.trsl.2016.06.005 · Cited by 28
Zhang, M., Gillaspy, A. F., Gipson, J. R., Cassidy, B. R., Nave, J. L., Brewer, M. F., Stoner, J. A., chen, J., & Drevets, D. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02751 · Cited by 29
The miRNA neuroinflammatory biomarkers in COVID-19 patients with different severity of illness
Keikha, R., Hashemi‐Shahri, S. M., & Jebali, A. (2021) · Neurología · doi:10.1016/j.nrl.2021.06.005 · Cited by 29
Noncoding RNAs and Their Potential Therapeutic Applications in Tissue Engineering
Li, S., Qian, T., Wang, X., Liu, J., & Gu, X. (2017) · Engineering · doi:10.1016/j.eng.2017.01.005 · Cited by 28
Cassidy, B. R., Zhang, M., Sonntag, W. E., & Drevets, D. A. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01929-8 · Cited by 27
Microglial activation in Alzheimer's disease: The role of flavonoids and microRNAs
Medrano-Jiménez, E., Meza‐Sosa, K. F., Aragon, J. A. U., Secundino, I., Pedraza-Alva, G., & Pérez-Martínez, L. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr1021-531r · Cited by 28
Sobuś, A., Baumert, B., Litwińska, Z., Gołąb-Janowska, M., Stępniewski, J., Kotowski, M., Pius‐Sadowska, E., Kawa, M. P., Gródecka-Szwajkiewicz, D., Peregud-Pogorzelski, J. W., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051312 · Cited by 27
Zhou, X., Chen, J., Tao, H., Cai, Y., Huang, L., Zhou, H., Chen, Y., Cui, L., Zhong, W., & Li, K. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s247677 · Cited by 26
Maurya, S. K., Gupta, S., & Mishra, R. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1072046 · Cited by 26
Sharma, M., Tanwar, A. K., Purohit, P. K., Pal, P., Kumar, D., Vaidya, S., Prajapati, S. K., Kumar, A., Dhama, N., Kumar, S., et al. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105685 · Cited by 27
Increased Expression of miR‐155p5 in Amygdala of Children With Autism Spectrum Disorder
Almehmadi, K., Tsilioni, I., & Theoharides, T. C. (2019) · Autism Research · doi:10.1002/aur.2205 · Cited by 26
Suofu, Y., Wang, X., He, Y., Li, F., Zhang, Y., Carlisle, D. L., & Friedlander, R. M. (2019) · Neuroreport · doi:10.1097/wnr.0000000000001382 · Cited by 26
MicroRNAs as Regulators of Phagocytosis
Gierlikowski, W., & Gierlikowska, B. (2022) · Cells · doi:10.3390/cells11091380 · Cited by 25
MicroRNAs in the Spinal Microglia Serve Critical Roles in Neuropathic Pain
Tang, S., Jing, H., Song, F., Huang, H., Li, W., Xie, G., & Zhou, J. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02102-1 · Cited by 25
Aggio‐Bruce, R., Chu‐Tan, J. A., Wooff, Y., Cioanca, A. V., Schümann, U., & Natoli, R. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02158-z · Cited by 26
Lussier, A. A., Bodnar, T. S., & Weinberg, J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.788630 · Cited by 26
The miRNA neuroinflammatory biomarkers in COVID-19 patients with different severity of illness
Keikha, R., Hashemi‐Shahri, S. M., & Jebali, A. (2023) · Neurología (English Edition) · doi:10.1016/j.nrleng.2023.05.002 · Cited by 25
Use of microRNAs as Diagnostic, Prognostic, and Therapeutic Tools for Glioblastoma
Valle‐García, D., de la Cruz, V. P., Flores, I., Salazar, A., Pineda, B., & Meza‐Sosa, K. F. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052464 · Cited by 26
Ren, J. P., Ying, R. S., Cheng, Y., Wang, L., Gazzar, M. E., Li, G. Y., Ning, S., Moorman, J. P., & Yao, Z. Q. (2016) · Journal of Viral Hepatitis · doi:10.1111/jvh.12537 · Cited by 25
Zhang, W., Wang, L., Pang, X., Zhang, J., & Guan, Y. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14358 · Cited by 24
Tuttolomondo, A., Daidone, M., Cataldi, M., & Pinto, A. V. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.310607 · Cited by 23
The role of miRNAs in multiple sclerosis pathogenesis, diagnosis, and therapeutic resistance
Doghish, A. S., Elazazy, O. E., Mohamed, H. H., Mansour, R. M., Ghanem, A., Faraag, A. H. I., Elballal, M. S., Elrebehy, M. A., Elesawy, A. E., Mageed, S. S. A., et al. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154880 · Cited by 23
Xu, H., Fang, X., Zhu, S.-H., Xu, X.-H., Zhang, Z.-X., Wang, Z., Zhao, Z., Ding, Y.-J., & Tao, L. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5716 · Cited by 23
Sun, X., Sun, J., Shao, X., Feng, J., Yan, J., & Qin, Y. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6032 · Cited by 24
Metadata
- Authors
- Cardoso, A. L., Guedes, J. R., Pereira de Almeida, L., & Pedroso de Lima, M. C.
- Affiliations
- Centro de Neurociências e Biologia Celular (PT)
- University of Coimbra (PT)
- Corresponding author
- Cardoso, Ana L.
- Venue
- Immunology
- Publisher
- Wiley
- Published
- 2011-12-07
- Volume
- 135
- Issue
- 1
- Pages
- 73-88
- ISSN
- 0019-2805 (ISSN-L)
- 1365-2567
- PMC
- PMC3246654
- OpenAlex
- W2095876795
- Cited by
- 336
- References
- 32
- Citations by year
- 2026: 16 · 2025: 24 · 2024: 17 · 2023: 26 · 2022: 21 · 2021: 29 · 2020: 34 · 2019: 24 · 2018: 25 · 2017: 26 · 2016: 25 · 2015: 20 · 2014: 29 · 2013: 15 · 2012: 5
- FWCI
- 8.67
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Immunology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- miR-155, microglia, SOCS1, innate immunity, neuroinflammation, lipopolysaccharide, nitric oxide, inducible nitric oxide synthase, inflammatory cytokines, microglial activation, neuronal cell death, neuroprotection, antagomir
- MeSH terms
- Suppressor of Cytokine Signaling 1 Protein, Animals, Cells, Cultured, Lipopolysaccharides, Nitric Oxide, Down-Regulation, Up-Regulation, Cytokines, Microglia, MicroRNAs, Suppressor of Cytokine Signaling Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
